Development of a Clinical and Biological Database in Rectum Cancer

Launched by INSTITUT DU CANCER DE MONTPELLIER - VAL D'AURELLE · Jul 1, 2019

Keywords

ClinConnect Summary

This clinical trial is focused on creating a special database that will collect information about patients with rectal cancer. The goal is to gather blood and tissue samples, along with clinical data, to help researchers better understand rectal cancer and develop new treatments. This database will be a valuable resource for scientists and doctors working to improve care for patients with this condition.

To join the study, participants need to be at least 18 years old and have received treatment for rectal cancer at the Montpellier Cancer Institute, regardless of the type of treatment they received. It's also important that they can understand and follow the study requirements. Participants will be asked to provide informed consent, meaning they agree to be part of the study after being fully informed about its purpose and procedures. This is a great opportunity to contribute to cancer research, and every participant's contribution can make a difference in finding better ways to treat rectal cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient treated at the Montpellier Cancer Institute, whatever the treatment received (systemic cancer treatment or radiotherapy or surgery)
• • Age \> 18 years
• • Signed informed consent
• Exclusion Criteria:
• • Patient not affiliated to Social Protection system
• • Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons
• • Patient under guardianship